Four advanced science institutes in Japan have agreed to form an association in a move designed to speed up the development of new vaccines, the Daily Yomiuri reports. The collaboration between the science units would help local drugmakers by circulating useful research data between them.
The four participating R&D centers are: the National Institute of Infectious Diseases, the Institute of Medical Science at Tokyo University, the Research Institute for Microbial Diseases and the National Institute for Biomedical Innovation. Observers in the association, which is due to begin operations in the fall, include the Ministry of Health, Labor and Welfare, the Association of Biologicals Manufacturers of Japan and the Japan Pharmaceutical Manufacturers Association.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze